admin

FREDERICK, MD (October 24, 2022) – The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, has named the Honorable Kelly M. Schulz, a former cybersecurity small business partner, state legislator, and two-time state cabinet secretary, as its new CEO.

As Secretary of the Maryland Department of Commerce from 2019 to 2021, Schulz oversaw the state’s primary economic development agency, responsible for attracting new businesses, promoting innovation, and accelerating job growth. Under her leadership, the department served as the largest resource to provide financial assistance to struggling Maryland companies adversely impacted by COVID-19. She previously served as Secretary of the Maryland Department of Labor from 2015 to 2018. During her tenure, Maryland’s apprenticeship program grew to its highest level since 2008, with more than 10,000 apprentices statewide and received national recognition as one of America’s top programs.

Oct 19 (Reuters) – JPMorgan Chase & Co (JPM.N) is launching a platform that aims to connect startup founders with venture capital investors to simplify the fundraising process, the bank told Reuters.

The new platform, Capital Connect, focuses on serving the financing needs of startups from their early stages, marking the ambition of the biggest U.S. bank by assets to further expand into the private market and build a founder-friendly brand in Silicon Valley.

20 weeks’ journey of US Market Entry Program is finally completed. The program is to provide soft landing for medical start-ups from Korea. 5 start-up cohorts, after competitive selection, have been fostered by BioHealth Innovation (BHI) and KOSME (Korea SMEs and Startups Agency).

The synergy between strong Korean Government support and local expertise delivered significant impact to us. Congratulations to 5 cohort start-ups for successfully achieved the mission !

Medtronic (NYSE:MDT) revealed its plans for an incubation and acceleration platform for innovation in the neurovascular space.

In a presentation yesterday at DeviceTalks West in Santa Clara, California, the company unveiled its plan to bring innovations to market to address strokes. Daniel Volz, president of Medtronic Neurovascular, and Derek Crittenden, Medtronic’s new technology & strategy program manager, presented the news.

Image: Dan Volz (right) and Derek Crittenden (left) present the Medtronic Co-Lab program at DeviceTalks West in Santa Clara, California. – https://www.massdevice.com

The entrepreneurial spirit burns bright at Johns Hopkins University, with alumni launching startups in sectors ranging from life sciences to the metaverse.

Enter A-Level Capital, a group of budding undergraduate investors on a mission to help Hopkins-born startups succeed. Founded by Carey Business School alum Elizabeth Galbut and Whiting School of Engineering alum Demi Obayomi, the student-run venture capital firm targets early-stage companies created or run by Hopkins alumni.

Image: https://hub.jhu.edu/

Johns Hopkins University is one of several partners behind the launch of The Light of Baltimore Incubator at Baker Donelson, a partnership with Bloomberg Philanthropies and Goldman Sachs 10,000 Small Businesses, to provide office space, mentorship, and legal and marketing support for 26 HopkinsLocal businesses and other regional small businesses.

Image: https://hub.jhu.edu

Enrollment has begun in an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. aeruginosa) in their lungs. The trial is evaluating whether the bacteriophage, or “phage,” therapy is safe and able to reduce the amount of bacteria in the lungs of volunteers. The trial is being conducted by the Antibacterial Resistance Leadership Group (ARLG), funded by the National Institute of Allergy and Infectious Diseases. Investigators aim to enroll up to 72 adults at 16 CF centers across the United States.

AMPEL Biosolutions (AMPEL), located in Charlottesville, Virginia is a leading personalized precision medicine company developing tools that can help autoimmune and inflammatory disease patients improve their quality of life. AMPEL is one of the exciting companies that have emerged from the Charlottesville (CVille) biohub clustered around the University of Virginia (UVA).

Image: https://biobuzz.io

A throng of entrepreneurs, academics, developers and prominent life sciences players milled about two construction vehicles parked on a vacant, grass-covered lot at West Fayette Street and Martin Luther King Jr. Boulevard in West Baltimore Friday afternoon.

The crowd came to celebrate the start of construction on 4MLK, a project that has been in the works for nearly a decade and will eventually provide the local life sciences sector with badly needed wet lab space.